IL6 and breast carcinoma: IL-8 typically recruits and activates macrophages upon tissue over-injury, induces epithelial–mesenchymal transition, and, combined with an IL-6 to IL-8 ratio of 3.0, upregulates cyclin D1 to drive breast cancer cell proliferation [23].